Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses

Nanotoxicology

Volumn 7, Issue 2, 2013, Pages 157-168

  Azad, Neelam ^a   Iyer, Anand Krishnan V ^a   Wang, Liying ^b   Liu, Yuxin ^c   Lu, Yongju ^d   Rojanasakul, Yon ^d  

^a HAMPTON UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c West Virginia University   (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Angiogenesis; P38 MAPK; SWCNTs; TGF 1; VEGF

Indexed keywords

COLLAGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SINGLE WALLED NANOTUBE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

CELL LINE; CELL PROLIFERATION; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FEEDBACK, PHYSIOLOGICAL; FIBROBLASTS; FIBROSIS; HUMANS; NANOTUBES, CARBON; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PULMONARY FIBROSIS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873334239     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2011.647929     Document Type: Article

References (57)

1. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, et al. 1996. The p38/RK mitogen-Activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. Embo J 15:1914-1923
2. Brinckerhoff CE, Matrisian LM. 2002. Matrix metalloproteinases: A tail of a frog that became a prince. Nat Rev Mol Cell Biol 3:207-214
3. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395
4. Clark RA, Mason RJ, Folkvord JM, Mcdonald JA. 1986. Fibronectin mediates adherence of rat alveolar type II epithelial cells via the fibroblastic cell-Attachment domain. J Clin Invest 77:1831-1840
5. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, Du Bois RM, Jeffery PK, et al. 1997. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 150:981-991
6. Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, et al. 2004. Pigment epithelium-Derived factor in idiopathic pulmonary fibrosis: A role in aberrant angiogenesis. Am J Respir Crit Care Med 170:242-251
7. Crouch E. 1990. Pathobiology of pulmonary fibrosis. Am J Physiol 259: L159-L184
8. Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, et al. 2004. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-Mediated lung fibrosis. J Clin Invest 114:1308-1316
9. Demyanets S, Kaun C, Rychli K, Pfaffenberger S, Kastl SP, Hohensinner PJ, et al. 2011. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- And STAT1/STAT3- dependent pathways and is attenuated by interferon-gamma. Basic Res Cardiol 106:217-231
10. Fehrenbach H, Kasper M, Haase M, Schuh D, Muller M. 1999. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: Light, fluorescence, and electron microscopy. Anat Rec 254:61-73
11. Goldberg PL, Macnaughton DE, Clements RT, Minnear FL, Vincent PA. 2002. p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability. Am J Physiol Lung Cell Mol Physiol 282:L146-L154
12. Han J, Lee JD, Bibbs L, Ulevitch RJ. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811
13. Helmlinger G, Endo M, Ferrara N, Hlatky L, Jain RK. 2000. Formation of endothelial cell networks. Nature 405:139-141
14. Hiratsuka S, Duda DG, Huang Y, Goel S, Sugiyama T, Nagasawa T, et al. 2011. C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-Activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells. Proc Natl Acad Sci USA 108:302-307
15. Huh JE, Nam DW, Baek YH, Kang JW, Park DS, Choi DY, et al. 2011. Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways. Int Immunopharmacol 11:46-54
16. Inghilleri S, Morbini P, Oggionni T, Barni S, Fenoglio C. 2006. In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis. Histochem Cell Biol 125:661-669
17. Iordanov M, Bender K, Ade T, Schmid W, Sachsenmaier C, Engel K, et al. 1997. CREB is activated by UVC through a p38/ HOG-1-Dependent protein kinase. Embo J 16:1009-1022
18. Kang HR, Lee CG, Homer RJ, Elias JA. 2007. Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J Exp Med 204:1083-1093
19. Keane MP, Arenberg DA, Lynch JP III, Whyte RI, Iannettoni MD, Burdick MD, et al. 1997. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 159:1437-1443
20. Keane MP, Belperio JA, Arenberg DA, Burdick MD, Xu ZJ, Xue YY, et al. 1999a. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 163:5686-5692
21. Keane MP, Belperio JA, Burdick MD, Lynch JP, Fishbein MC, Strieter RM. 2001. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 164:2239-2242
22. Keane MP, Belperio JA, Moore TA, Moore BB, Arenberg DA, Smith RE, et al. 1999b. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol 162:5511-5518
23. Khalil N, Parekh TV, O'Connor R, Antman N, Kepron W, Yehaulaeshet T, et al. 2001. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis. Thorax 56:907-915
24. Kolosova I, Nethery D, Kern JA. 2011. Role of Smad2/3 and p38 MAP kinase in TGF-beta1-induced epithelial-Mesenchymal transition of pulmonary epithelial cells. J Cell Physiol 226:1248-1254
25. Lam CW, James JT, Mccluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126-134
26. Lu Y, Azad N, Wang L, Iyer AK, Castranova V, Jiang BH, et al. 2010. Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production. Am J Respir Cell Mol Biol 42:432-441
27. Mcanulty RJ, Laurent GJ. 1995. Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp Nephrol 3:96-107
28. Meyer KC, Cardoni A, Xiang ZZ. 2000. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 135:332-338
29. Moriguchi T, Toyoshima F, Gotoh Y, Iwamatsu A, Irie K, Mori E, et al. 1996. Purification and identification of a major activator for p38 from osmotically shocked cells. Activation of mitogen-Activated protein kinase kinase 6 by osmotic shock, tumor necrosis factoralpha, and H2O2. J Biol Chem 271:26981-26988
30. Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839
31. Pandey P, Raingeaud J, Kaneki M, Weichselbaum R, Davis RJ, Kufe D, et al. 1996. Activation of p38 mitogen-Activated protein kinase by c-Abl-Dependent and -independent mechanisms. J Biol Chem 271:23775-23779
32. Papakonstantinou E, Aletras AJ, Roth M, Tamm M, Karakiulakis G. 2003. Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts. Cytokine 24:25-35
33. Pardo A, Selman M. 2005. MMP-1: The elder of the family. Int J Biochem Cell Biol 37:283-288
34. Peao MN, Aguas AP, De Sa CM, Grande NR. 1994. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec 238:57-67
35. Pelton RW, Nomura S, Moses HL, Hogan BL. 1989. Expression of transforming growth factor beta 2 RNA during murine embryogenesis. Development 106:759-767
36. Quinlan T, Spivack S, Mossman BT. 1994. Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 102 (SUPPL2):79-87
37. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, et al. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-Activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426
38. Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, et al. 2003. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 167:438-443
39. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, et al. 1986. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171
40. Roos TU, Heiss EH, Schwaiberger AV, Schachner D, Sroka IM, Oberan T, et al. 2011. Caffeic acid phenethyl ester inhibits PDGFInduced proliferation of vascular smooth muscle cells via activation of p38 MAPK, HIF-1alpha, and Heme Oxygenase-1. J Nat Prod 74:352-356
41. Selman M, King TE, Pardo A. 2001. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134:136-151
42. Selman M, Montano M, Ramos C, Chapela R. 1986. Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax 41:355-359
43. Shields KM, Panzhinskiy E, Burns N, Zawada WM, Das M. 2011. Mitogen-Activated protein kinase phosphatase-1 is a key regulator of hypoxia-induced vascular endothelial growth factor expression and vessel density in lung. Am J Pathol 178:98-109
44. Shvedova AA, Kagan VE. 2010. The role of nanotoxicology in realizing the 'helping without harm' paradigm of nanomedicine: Lessons from studies of pulmonary effects of single-walled carbon nanotubes. J Intern Med 267:106-118
45. Shvedova AA, Kisin E, Murray AR, Johnson VJ, Gorelik O, Arepalli S, et al. 2008. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: Inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol 295: L552-L565
46. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, et al. 2005. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289:L698-L708
47. Sorensen V, Zhen Y, Zakrzewska M, Haugsten EM, Walchli S, Nilsen T, et al. 2008. Phosphorylation of fibroblast growth factor (FGF) receptor 1 at Ser777 by p38 mitogen-Activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus. Mol Cell Biol 28:4129-4141
48. Steurer M, Zoller H, Augustin F, Fong D, Heiss S, Strasser-Weippl K, et al. 2007. Increased angiogenesis in chronic idiopathic myelofibrosis: Vascular endothelial growth factor as a prominent angiogenic factor. Hum Pathol 38:1057-1064
49. Thannickal VJ, Toews GB, White ES, Lynch JP III, Martinez FJ. 2004. Mechanisms of pulmonary fibrosis. Annu Rev Med 55:395-417
50. Turner-Warwick M. 1963. Precapillary Systemic-Pulmonary Anastomoses. Thorax 18:225-237
51. Wang L, Castranova V, Mishra A, Chen B, Mercer RR, Schwegler-Berry D, et al. 2010a. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol 7:31
52. Wang L, Mercer RR, Rojanasakul Y, Qiu A, Lu Y, Scabilloni JF, et al. 2010b. Direct fibrogenic effects of dispersed single-walled carbon nanotubes on human lung fibroblasts. J Toxicol Environ Health A 73:410-422
53. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 77:117-125
54. Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE, et al. 2001. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-Activated p38 signaling pathway enhances endothelial cell migration. Cancer Res 61: 1727-1732
55. Xu YD, Hua J, Mui A, O'Connor R, Grotendorst G, Khalil N. 2003. Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 285:L527-L539
56. Yang EY, Moses HL. 1990. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111:731-741
57. Zhang P, Xu D, Wang S, FU H, Wang K, Zou Y, et al. 2011. Inhibition of aldehyde dehydrogenase 2 activity enhances antimycin-induced rat cardiomyocytes apoptosis through activation of MAPK signaling pathway. Biomed Pharmacother 65(8):590-593